THE SIMMONS & RUSSELL GROUP, LLC for ELI LILLY AND COMPANY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to the pharmaceutical industry including drug pricing, drug value, and the 340B Program. Issues related to healthcare policy and cost; Lower Health Care Costs Act of 2019, S.1895. Healthcare issues related to the CARES Act, H.R.748, P.L.116-136 implementation and additional COVID-19 legislative proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Taxation/Internal Revenue Code TAX
Issues related to the implementation of the Tax Cuts and Jobs Act, P.L.115-97.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D coverage and reimbursement policies. Issues related to Medicaid reimbursement. Issues related to drug pricing; Prescription Drug Pricing Reduction Act of 2019, S.2543.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.